The decision to screen for prostate cancer is a complicated one. A Cleveland Clinic medical oncologist discusses overdiagnosis and recommends a new path forward.
Prescribing Testosterone and DHEA: The Role of Androgens in Women
The physiologic roles of androgens and best-practice recommendations for androgen therapy in women.
At-Home COVID-19 Tests: How They Perform, And What Clinicians Should Know
A team of Cleveland Clinic experts considers the clinical implications of at-home COVID-19 tests in a recent article.
Unique Aspects of COVID-19 in Children
What to look for and how to manage symptoms of COVID-19 in the pediatric population.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Gadolinium-Induced Nephrogenic Systemic Fibrosis: Classification, Risk and Guidelines
The relationship between nephrogenic systemic fibrosis and the use of gadolinium as contrast during MRI remained obscure for a long time. Cleveland Clinic nephrologists discuss the current literature, risks and updated guidelines.
Ophthalmic Presentations of COVID-19
Studying the ophthalmic effects of COVID-19 infection could potentially lead to earlier diagnosis and aid in disease management.
IL-6 Targeting in COVID-19 Treatment
New data question the efficacy of IL-6 inhibitors for the treatment of COVID-19. This article explores what we know about the safety and efficacy of targeting IL-6.
Bronchoscopic Lung Volume Reduction With Valves: What Should the Internist Know?
Cleveland Clinic pulmonologists discuss the limitations of current modalities designed to treat emphysema and review the rationale, evidence and applications of valve therapy.
Community-Acquired Pneumonia: New Considerations for an Old Infection
Clinicians have been treating community-acquired pneumonia (CAP) for centuries. Clinical and scientific discoveries have shifted the treatment paradigm over the years, but understanding current guidelines for the management of CAP remains essential.
COVID-19 and Underlying Chronic Lung Disease: What Is Known About Risk and Managing Care
Patients with COVID-19 who have underlying chronic lung disease are at increased risk for developing severe illness. Pulmonologist Brian Southern, MD, recently authored a review article in Cleveland Clinic Journal of Medicine’s COVID-19 Curbside Consults series. In this article, he takes a closer look at what is known about ILD and sarcoidosis in the context of the pandemic and offers insights for managing care.